Neoadjuvant chemoradiotherapy followed by active surveillance versus standard surgery for oesophageal cancer (SANO trial): a multicentre, stepped-wedge, cluster-randomised, non-inferiority, phase 3 trial

Berend J. van der Wilk*, Ben M. Eyck, SANO study group, Bas P.L. Wijnhoven, Sjoerd M. Lagarde, Camiel Rosman, Bo J. Noordman, Maria J. Valkema, Tanya M. Bisseling, Peter Paul L.O. Coene, Marc J. van Det, Jan Willem T. Dekker, Jolanda M. van Dieren, Michail Doukas, Stijn van Esser, W. Edward Fiets, Henk H. Hartgrink, Joos Heisterkamp, I. Lisanne Holster, Bastiaan KlarenbeekDavid van Klaveren, Eva Kouw, Ewout A. Kouwenhoven, Misha D. Luyer, Bianca Mostert, Grard A.P. Nieuwenhuijzen, Liekele E. Oostenbrug, Jean Pierre E.N. Pierie, Johanna W. van Sandick, Meindert N. Sosef, Manon C.W. Spaander, Roelf Valkema, Edwin S. van der Zaag, Ewout W. Steyerberg, J. Jan B. van Lanschot

*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

12 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Neoadjuvant chemoradiotherapy followed by active surveillance versus standard surgery for oesophageal cancer (SANO trial): a multicentre, stepped-wedge, cluster-randomised, non-inferiority, phase 3 trial'. Together they form a unique fingerprint.

Medicine and Dentistry